Ceramide C6-d7
Based on 1 Customer Validation
Ceramide C6-d7 is the deuterium labeled Ceramide C6. Ceramide C6, a Ceramide pathway activator, is an exogenous short-chain ceramide which can induce apoptosis of multiple cancer cells.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.0%
- CAS No.: 2692624-22-7
- Formule: C24H40D7NO3
- Masse moléculaire:404.68
-
Stockage:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-100355S1
C18-Ceramide-d7
-
HY-116258S
C16 Ceramide-d7 (d16:1,C16:0)
-
HY-152022S
EOS (d18:1/32:0/18:2)-d9
-
HY-141580S1
C18 Dihydroceramide-d3-1
-
HY-152020S
Sphingosine-d9 (d18:1)
-
HY-141629S2
N-Palmitoyl-D-sphingomyelin-d9
-
HY-134508S
C24-Ceramide-d7
-
HY-134575S
C24:1-Ceramide-d7
-
HY-100355S
C18-Ceramide-d3
-
HY-W698686S
β-Galactosyl-C18-ceramide-d35
-
HY-116392B
DL-threo-PDMP hydrochloride
-
HY-N7745S2
Glucosylsphingosine-13C6
Activité biologique
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 2692624-22-7
-
Unlabeled CAS 124753-97-5
-
Appearance Liquid
-
Masse moléculaire 404.68
-
Formule C24H40D7NO3
-
Color Colorless to light yellow
-
SMILES
OC[C@@H]([C@@H](/C=C/CCCCCCCCCCC([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])O)NC(CCCCC)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Solution, -20°C, 2 years
Pureté et documentation
-
Fiche technique (268 KB)
-
SDS (737 KB)
- English - EN (737 KB)
- Français - FR (737 KB)
- Deutsch - DE (737 KB)
- Norwegian - NO (737 KB)
- Español - ES (737 KB)
- Swedish - SV (737 KB)
- Italian - IT (737 KB)
- Korean - KR (737 KB)
- Portuguese - PT (737 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
[2]. Qiu L, et al. C6-ceramide induces salivary adenoid cystic carcinoma cell apoptosis via IP3R-activated UPR and UPR-independent pathways. Biochem Biophys Res Commun. 2020;525(4):997-1003. [Content Brief]
[3]. Liu L, et al. C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway. J Transl Med. 2020;18(1):298. Published 2020 Aug 3. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ceramide C6-d7 Related Classifications
HY-19542S Related Classifications
Powered by Bioz